BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2285740)

  • 1. Achieving consensus on an algorithm for the treatment of rheumatoid arthritis with methotrexate.
    Ambrose RF; Moreland LW; Kendall LG; Brown S; Koopman WJ; Alarcón GS
    Arthritis Care Res; 1990 Mar; 3(1):53-7. PubMed ID: 2285740
    [No Abstract]   [Full Text] [Related]  

  • 2. Discussion. Treatment algorithm: managing rheumatoid arthritis.
    Calabrese DC; Konop R; Cannon E; Maves TK; Casberg JJ; Meske L; Coleman IC; Orland BI; Florentine MJ; Southwell Y; Harris MR; Yoder DM
    Manag Care; 2001 Jul; 10(7 Suppl):19-24. PubMed ID: 11729430
    [No Abstract]   [Full Text] [Related]  

  • 3. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
    Fautrel B; Guillemin F; Meyer O; de Bandt M; Berthelot JM; Flipo RM; Lioté F; Maillefert JF; Wendling D; Saraux A; Combe B; Le Loët X; ; ;
    Arthritis Rheum; 2009 Apr; 61(4):425-34. PubMed ID: 19333993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Most rheumatologists are conservative in active rheumatoid arthritis despite methotrexate therapy: results of the PRISME survey.
    Saraux A; Devauchelle-Pensec V; Engerran L; Flipo RM
    J Rheumatol; 2006 Jul; 33(7):1258-65. PubMed ID: 16783865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey.
    Maetzel A; Bombardier C; Strand V; Tugwell P; Wells G
    J Rheumatol; 1998 Dec; 25(12):2331-8. PubMed ID: 9858426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with methotrexate in patients with rheumatoid arthritis].
    Bijlsma JW
    Ned Tijdschr Geneeskd; 1987 Dec; 131(51):2348-52. PubMed ID: 3320769
    [No Abstract]   [Full Text] [Related]  

  • 7. Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice.
    Buchbinder R; Hall S; Sambrook PN; Champion GD; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
    J Rheumatol; 1993 Apr; 20(4):639-44. PubMed ID: 8496857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis.
    Galindo-Rodriguez G; Avina-Zubieta JA; Fitzgerald A; LeClerq SA; Russell AS; Suarez-Almazor ME
    J Rheumatol; 1997 Apr; 24(4):633-8. PubMed ID: 9101493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methotrexate: mainstay of rheumatoid arthritis treatment].
    Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 2009; 153():A879. PubMed ID: 19785862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.
    Chakravarty EF; Sanchez-Yamamoto D; Bush TM
    J Rheumatol; 2003 Feb; 30(2):241-6. PubMed ID: 12563675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintaining and optimising anti-TNF therapy.
    Somerville M
    Musculoskeletal Care; 2007 Dec; 5 Suppl 1():1-17. PubMed ID: 18050263
    [No Abstract]   [Full Text] [Related]  

  • 12. Methotrexate for rheumatoid arthritis.
    Agarwal AK; Wali M; Chandra S; Jain A; Wadhwa S
    J Assoc Physicians India; 1994 Nov; 42(11):888-90. PubMed ID: 7868493
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions.
    Kinder AJ; Hassell AB; Brand J; Brownfield A; Grove M; Shadforth MF
    Rheumatology (Oxford); 2005 Jan; 44(1):61-6. PubMed ID: 15611303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do French rheumatologists treat early rheumatoid arthritis?
    de Asit N; Le Loët X; Czernichow P; Bertho JM; Delcambre B; Tonnel F; Loyau G; Dapogny C; Trèves R; Valat JP; Tauveron P; Sebert JL; Boumier P
    Rev Rhum Engl Ed; 1996 Mar; 63(3):188-95. PubMed ID: 8731236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate: a perspective on its use for rheumatoid arthritis.
    Weinstein A
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():1-2. PubMed ID: 3831361
    [No Abstract]   [Full Text] [Related]  

  • 16. [Methotrexate treatment of rheumatoid arthritis].
    Beyeler C
    Schweiz Med Wochenschr; 1996 Apr; 126(17):703-12. PubMed ID: 8668981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics.
    Carli C; Ehlin AG; Klareskog L; Lindblad S; Montgomery SM
    Ann Rheum Dis; 2006 Aug; 65(8):1102-5. PubMed ID: 16322085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Listeria monocytogenes infection in a patient treated with methotrexate for rheumatoid arthritis.
    McCambridge MM; Vogelgesang SA; Ockenhouse CF
    J Rheumatol; 1995 Apr; 22(4):786-7. PubMed ID: 7791185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chinese expert-based consensus for methotrexate in rheumatic diseases].
    Chinese Association of Rheumatology and Immunology Physicians
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):719-722. PubMed ID: 30293331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria].
    Niehues T; Horneff G; Michels H; Sailer Höck M; Schuchmann L
    Z Rheumatol; 2004 Apr; 63(2):147-58. PubMed ID: 15112095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.